Delivery Order SPE2DR25D1034-SPE2DR26FPV6V
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a $41,540.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packages of 30 units. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a $55,387.88 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Vyndamax 61 mg capsule unit dose packs (30-count). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 20, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor...
- The Defense Logistics Agency awarded a $41,541 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This is a firm fixed-price delivery order with no set-aside designation, issued under full and open competition. The contract is scheduled for completion by November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract, issued under firm fixed pricing with no set-aside designation, is scheduled for completion by September 24, 2025, and represents a competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $13,846.97 and has a firm fixed price structure with an ultimate completion date of September 18, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This is a firm fixed price delivery order with completion scheduled for October 10, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on August 22, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packaging (30-count) on August 8, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPV6VDelivery Order
The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitively awarded, firm fixed-price delivery order is set to be completed by November 21, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The broader SPE2DX IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 10/30/25 |